Skip to main content
. 2020 Aug 7;6(8):e04589. doi: 10.1016/j.heliyon.2020.e04589

Table 1.

Composition of trial batches.

PLGA Concentration P80 concentration
(mg)
Cycles
(numbers)
PVA Concentration
(%)
300 600 4 1
100 300 4 1
300 300 4 1
100 600 4 1
100 300 6 1
100 300 4 2
500 300 4 1